CLINICAL_TRIALS
trial_result
· 2019-01-15
Clinical Trial Update: Aflibercept in Polypoidal Choroidal Vasculopathy [Phase 4]
Summary
Phase 4 trial update evaluating aflibercept for neovascular macular degeneration has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Neovascular Macular Degeneration | Phase 4 | Status: COMPLETED | Results posted: 2019-01-15